Padcev is approved for use in combination with the programmed death 1 inhibitor Keytruda (pembrolizumab) or Keytruda QLEX (pembrolizumab and berahyaluronidase alfa-pmph) as neoadjuvant treatment and ...

For individuals facing fear, uncertainty and repeated procedures associated with recurrent low-grade intermediate-risk bladder tumors, timely access to treatment can be critical. ZUSDURI, the first ...

He was previously fined for leaving a towel inside a patient. This is the fourth time in the last eight years his insurance ...

But Luis's addiction spiralled during lockdown, when he began snorting between three-and-half grams and seven grams of the ...